United Services Automobile Association’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-6,601
Closed -$289K 2229
2019
Q2
$289K Buy
6,601
+1,187
+22% +$66.9K ﹤0.01% 1898
2019
Q1
$279K Buy
+5,414
New +$234K ﹤0.01% 1927
2018
Q4
Sell
-16,240
Closed -$610K 2367
2018
Q3
$610K Sell
16,240
-180
-1% -$6.62K ﹤0.01% 1593
2018
Q2
$649K Buy
16,420
+2,743
+20% +$87K ﹤0.01% 1576
2018
Q1
$352K Buy
+13,677
New +$409K ﹤0.01% 1833

Other funds holding BHVN

United Services Automobile Association's BHVN Position: Q3 2019 in Review

United Services Automobile Association sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2019, closing a stake of 6,601 shares — an estimated $289K sold.

United Services Automobile Association first reported a position in BHVN in Q1 2018 and held it in 5 quarters. The position peaked at $649K in Q2 2018. 184 funds tracked by Wall St. Rank hold BHVN as of Q3 2019.

  • United Services Automobile Association reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 6,601 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2019, an estimated $289K.
  • United Services Automobile Association first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2018 and held it in 5 quarters.
  • United Services Automobile Association's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $649K in Q2 2018.
  • 184 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.